Study of Hallucinations in Parkinson's Disease
Author Information
Author(s): Spiridon Papapetropoulos, Heather Katzen, Anette Schrag, Carlos Singer, Blake K Scanlon, Daniel Nation, Alexandra Guevara, Bonnie Levin
Primary Institution: University of Miami, Miller School of Medicine
Hypothesis
Can the University of Miami Parkinson's disease Hallucinations Questionnaire (UM-PDHQ) effectively characterize hallucinations in Parkinson's disease patients?
Conclusion
The UM-PDHQ successfully defined key characteristics of hallucinations in Parkinson's disease patients.
Supporting Evidence
- Hallucinations occur in 20-40% of Parkinson's disease patients.
- 31 out of 70 patients were classified as hallucinators.
- No significant differences were found between hallucinators and non-hallucinators in demographics or cognitive functioning.
Takeaway
This study created a questionnaire to help doctors understand hallucinations in people with Parkinson's disease better.
Methodology
The study used a 20-item questionnaire administered to Parkinson's disease patients to assess hallucinations.
Potential Biases
Potential bias due to reliance on self-reported data and the limited sensitivity of the MMSE for cognitive assessment.
Limitations
The UM-PDHQ does not provide an overall score of severity and is not a graded instrument.
Participant Demographics
70 patients (46 men, 24 women) with a mean age of 64.3 years.
Statistical Information
P-Value
p=0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website